ProPhase Labs, Inc. (PRPH)
NASDAQ: PRPH · Real-Time Price · USD
0.4400
-0.0200 (-4.35%)
At close: Mar 28, 2025, 4:00 PM
0.4492
+0.0092 (2.09%)
After-hours: Mar 28, 2025, 7:56 PM EDT
ProPhase Labs Revenue
ProPhase Labs had revenue of $3.15M in the quarter ending September 30, 2024, a decrease of -62.39%. This brings the company's revenue in the last twelve months to $12.75M, down -79.66% year-over-year. In the year 2023, ProPhase Labs had annual revenue of $44.38M, down -63.81%.
Revenue (ttm)
$12.75M
Revenue Growth
-79.66%
P/S Ratio
0.64
Revenue / Employee
$112,858
Employees
113
Market Cap
13.30M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 44.38M | -78.26M | -63.81% |
Dec 31, 2022 | 122.65M | 43.61M | 55.17% |
Dec 31, 2021 | 79.04M | 64.53M | 444.59% |
Dec 31, 2020 | 14.51M | 4.64M | 46.96% |
Dec 31, 2019 | 9.88M | -3.25M | -24.76% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.88B |
PRPH News
- 3 days ago - ProPhase Labs Inc. to Present 2024 Year End Financial Results on March 31, 2025 - GlobeNewsWire
- 23 days ago - ProPhase Labs to Present at the Investor Summit Virtual on March 11 - GlobeNewsWire
- 4 weeks ago - Diamond Equity Research Releases Update Note on ProPhase Labs Inc. (NASDAQ: PRPH) - GlobeNewsWire
- 4 weeks ago - ProPhase Labs Examines Strategic Opportunities to Leverage Its DTC Multi-Media Infrastructure with Telehealth Physician Networks for Prescription Drugs - GlobeNewsWire
- 5 weeks ago - ProPhase Labs Announces Excellent Progress with Crown Medical Collections Targeting Over $50 Million in Net Near-Term Cash Recovery from COVID-19 Receivables - GlobeNewsWire
- 5 weeks ago - ProPhase Labs hires Stuart Hollenshead as COO, the former COO and CBO of Barstool Sports - GlobeNewsWire
- 4 months ago - ProPhase Labs, Inc. (PRPH) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 4 months ago - ProPhase Labs Inc. to Present Third Quarter 2024 Financial Results on November 13, 2024 - GlobeNewsWire